Celestica: I've 3xed My Investment But I'm Still Buying More (Archive)
Celestica’s AI networking dominance, long‑runway capex, and rising margins still justify buying.
5-Minute Pitches
5-Minute Stock Pitches with zero lag. Expect 10–20 pitches focused on core stock drivers every month.
Energy Transfer: Lake Charles Shock, EBITDA Miss And A Bearish Rollover Into 2026 (Archive)
Energy Transfer’s growth stalls as Lake Charles is scrapped and bearish pressures build.
Nebius Group: Sold Out On AI Demand, But With A 1‑Year Capex Headache (Archive)
Nebius faces booming AI demand but wrestles with year-long capex and dilution risks.
Pfizer: Adjusted EPS Masks How Bad 2026 Really Looks (Archive)
Pfizer’s 2026 earnings reality looks far uglier than headline adjusted EPS suggests.
Lumentum Holdings' Momentum Is Enticing, But There Are Too Many Reasons To Stay Away (Archive)
AI-fueled laser demand collides with substitution, concentration, and valuation landmines for Lumentum.
Agnico Eagle Mines: One Of My Top Picks For 2026 (Archive)
Leveraged gold exposure via low-cost growth projects, attractive valuation, and supportive macro tailwinds.
Coinbase: Sell As The Fundamentals And Charts Both Roll Over (Archive)
Coinbase faces mounting revenue, margin and technical headwinds that threaten sustained underperformance.